WSG LOSS NOTICE: ROSEN, A TOP RANKED LAW FIRM, Reminds Wanda Sports Group Company Limited Investors of Important Deadline in Securities Class Action First Filed by the Firm – WSG
December 07, 2019 13:00 ET | The Rosen Law Firm PA
NEW YORK, Dec. 07, 2019 (GLOBE NEWSWIRE) -- Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Wanda Sports Group Company Limited (NASDAQ: WSG) pursuant...
GW logo.JPG
Greenwich Biosciences, a GW Pharmaceuticals Company, Presents New Data for EPIDIOLEX® (cannabidiol) in Patients with Tuberous Sclerosis Complex (TSC) at the American Epilepsy Society Annual Meeting
December 07, 2019 12:00 ET | GW Pharmaceuticals plc
CARLSBAD, Calif., Dec. 07, 2019 (GLOBE NEWSWIRE) -- GW Pharmaceuticals plc (Nasdaq: GWPH), the world leader in the science, development, and commercialization of cannabinoid prescription medicines,...
Aptose Biosciences Inc. logo
Aptose Presents Highlights From Corporate Event At ASH
December 07, 2019 11:00 ET | Aptose Biosciences, Inc.
SAN DIEGO, TORONTO and ORLANDO, Fla., Dec. 07, 2019 (GLOBE NEWSWIRE) -- Aptose Biosciences Inc. (NASDAQ: APTO, TSX: APS) released highlights from a corporate event and clinical update today held at...
MERIT LOSS ALERT: Rosen Law Firm Announces Filing of Securities Class Action Lawsuit Against Merit Medical Systems, Inc. – MMSI
December 07, 2019 10:00 ET | The Rosen Law Firm PA
NEW YORK, Dec. 07, 2019 (GLOBE NEWSWIRE) -- Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of the securities of Merit...
principia.jpg
Principia Presents Consistent Positive Data of PRN1008 for Immune Thrombocytopenia in Ongoing Phase 1/2 Trial
December 07, 2019 10:00 ET | Principia Biopharma Inc.
ORLANDO, Fla., Dec. 07, 2019 (GLOBE NEWSWIRE) -- Principia Biopharma Inc. (Nasdaq: PRNB), a late-stage biopharmaceutical company focused on developing novel therapies for immune mediated diseases,...
corvus_logo_small.jpg
Corvus Pharmaceuticals Presents Preclinical and Initial Clinical Data from the Phase 1/1b Trial of CPI-818 at the American Society of Hematology (ASH) Annual Meeting
December 07, 2019 09:00 ET | Corvus Pharmaceuticals, Inc.
BURLINGAME, Calif., Dec. 07, 2019 (GLOBE NEWSWIRE) -- Corvus Pharmaceuticals, Inc. (Nasdaq: CRVS), a clinical-stage biopharmaceutical company focused on the development and commercialization of...
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of AZZ, Inc. - AZZ
December 07, 2019 09:00 ET | Pomerantz LLP
NEW YORK, Dec. 07, 2019 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of AZZ, Inc. (“AZZ” or the “Company”) (NYSE: AZZ).   Such investors are advised to contact...
hagens.jpg
9-DAY DEADLINE ALERT: HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages ADTRAN (ADTN) Investors with Significant Losses to Contact Its Attorneys, Application Deadline Approaching
December 07, 2019 09:00 ET | Hagens Berman Sobol Shapiro LLP
SAN FRANCISCO, Dec. 07, 2019 (GLOBE NEWSWIRE) -- Hagens Berman urges ADTRAN, Inc. (NASDAQ: ADTN) investors who have suffered losses in excess of $50,000 to submit their losses now to learn if they...
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Wanda Sports Group Company Ltd - WSG
December 07, 2019 09:00 ET | Pomerantz LLP
NEW YORK, Dec. 07, 2019 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Wanda Sports Group Company Ltd. (“Canopy” or the “Company”) (NASDAQ:  WSG)  Such investors...
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Fiat Chrysler Automobiles N.V. - FCAU
December 07, 2019 09:00 ET | Pomerantz LLP
NEW YORK, Dec. 07, 2019 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Fiat Chrysler Automobiles N.V. (“Fiat Chrysler” or the “Company”) (NYSE: FCAU)  Such...